Top 10 stocks for today – 20th November 2023

20 Nov 2023 , 07:43 AM

Here are some of the stocks that may see significant price movement today.

Larsen & Toubro: The General Tax Authority of Qatar assessed a penalty of 4,86,80,120 QAR (approximately Rs 111.31 crore) for the fiscal year 2017 and 5,58,22,856 QAR (about Rs 127.64 crore) for the fiscal year 2018. The company has filed an appeal against the imposition of this penalty, believing it to be arbitrary and unwarranted.

Kotak Mahindra Bank: The private sector lender received an order from the Maharashtra Government Department of Goods and Services Tax levying an amount of Rs 34,99,796 towards Goods and Services Tax (GST) and interest and a penalty of Rs 1,64,936 for the alleged excess claim of GST credit and non-payment of GST under reverse charge in certain instances during the assessment period July 2017-March 2018.

Vedanta: CRISIL Ratings has downgraded the company’s long-term bank facilities and debt instruments to AA from AA+ and moved them to ‘Rating Watch with Developing Implications’ from ‘Rating Watch with Negative Implications’.

IndusInd Bank: The Reserve Bank of India has accepted the nomination of Arun Khurana as the bank’s full-time director (executive director) for a three-year term beginning November 16. Arun was the bank’s deputy CEO as well as the overall head of Global Markets Group (GMG).

Delhivery: Softbank, through its firm SVF Doorbell (Cayman), sold 1.83 crore equity shares, or 2.49% stake in the logistics company’s paid-up equity, in open market transactions at an average price of Rs 403.51 per share. The share sale cost Rs 738.64 crore.

Bajaj Finance: The company has stopped the issue of Existing Member Identification Cards (EMI cards) to new clients till the shortcomings identified by the RBI are addressed to their satisfaction.

Bharti Airtel: The Andhra Pradesh LSA’s Department of Telecommunications, Hyderabad, has levied a Rs 1.07 lakh fine for suspected breaches of subscriber verification regulations.

Aurobindo Pharma: The US Food and Drug Administration (US FDA) completed a pre-approval inspection (PAI) at APL Healthcare’s formulation production facilities in Telangana, Units I and III, with zero observations. The inspection, which took place from November 13 to 17, ended with a rating of No Action Indicated (NAI).

Exide Industries: The High Court issued a decision confirming the terms of the Settlement Agreement signed by the parties, Exide Industries, Vertiv Company Group Limited UK (VCGL), and Vertiv Energy (VEPL), while dismissing the claims that had been outstanding since 2006.

Cipla: The pharmaceutical business has signed a Facility Demand Guarantee in the amount of ZAR 945 million in favour of First Rand Bank, South Africa, in exchange for general banking facilities being extended to Medpro Pharmaceutica (Pty) Ltd. In South Africa, Medpro is a step-down, completely owned subsidiary of Cipla.

For feedback and suggestions, write to us at [e-mail]